Skip to main content
. 2021 Jun 12;38(7):4070–4081. doi: 10.1007/s12325-021-01801-y

Table 2.

Adverse drug reactions (ADR) reported in the study

ADR Number of ADR/number of subjects
Dysgeusia 33/8
Blurred vision 4/1
Abnormal sensation in eye 2/2
Photophobia 2/1
Headache 1/1
Throat irritation 1/1
Total number of ADRs/number of subjects with any ADR 43/9